Cargando…

Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study

BACKGROUND: The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial decreased major adverse cardiovascular events with very low‐dose rivaroxaban and aspirin in patients with coronary artery disease and peripheral artery disease. We examined the eligibility and potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheth, Maya S., Yu, Bing, Chu, Anna, Porter, Joan, Tam, Derrick Y, Ferreira‐Legere, Laura E., Goodman, Shaun G., Farkouh, Michael E., Ko, Dennis T., Abdel‐Qadir, Husam, Udell, Jacob A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798819/ https://www.ncbi.nlm.nih.gov/pubmed/36515238 http://dx.doi.org/10.1161/JAHA.122.026553

Ejemplares similares

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

Incidence of Major Cardiovascular Events in Immigrants to Ontario, Canada: The CANHEART Immigrant Study
por: Tu, Jack V., et al.
Publicado: (2015)

CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?
por: Hassan, Mohamed, et al.
Publicado: (2016)

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Cell Stress Proteins in Atherothrombosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2012)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Platelet-Derived Exosomes and Atherothrombosis
por: Wei, Kangkang, et al.
Publicado: (2022)

CD40L and Its Receptors in Atherothrombosis—An Update
por: Michel, Nathaly Anto, et al.
Publicado: (2017)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Atherothrombosis is a Thrombotic, not Inflammatory Disease
por: Sloop, Gregory D, et al.
Publicado: (2017)

C-Reactive Protein in Atherothrombosis and Angiogenesis
por: Badimon, Lina, et al.
Publicado: (2018)

Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis
por: Suades, Rosa, et al.
Publicado: (2022)

Review of Prasugrel for the Secondary Prevention of Atherothrombosis
por: Spinler, Sarah A., et al.
Publicado: (2009)

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

The coagulation system in atherothrombosis: Implications for new therapeutic strategies
por: Olie, Renske H., et al.
Publicado: (2018)

Sex-Based Differences in Severe Outcomes, Including Cardiovascular Hospitalization, in Adults With COVID-19 in Ontario, Canada
por: Behrouzi, Bahar, et al.
Publicado: (2023)

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease
por: Fimognari, Filippo Luca, et al.
Publicado: (2008)

PCSK9 Biology and Its Role in Atherothrombosis
por: Barale, Cristina, et al.
Publicado: (2021)

Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation
por: Ugovšek, Sabina, et al.
Publicado: (2021)

Association between Intestinal Microecological Changes and Atherothrombosis
por: Zhuo, Xinyu, et al.
Publicado: (2023)

The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications
por: Drysdale, Amelia, et al.
Publicado: (2023)

Exploring the associations between cardiovascular health measured with the CANHEART model and early cognitive impairment in a middle-aged population in Korea
por: Jeon, Ye Jin, et al.
Publicado: (2021)

Early invasive coronary angiography and acute ischaemic heart failure outcomes
por: Kosyakovsky, Leah B, et al.
Publicado: (2021)

Blood coagulation and the risk of atherothrombosis: a complex relationship
por: Spronk, Henri MH, et al.
Publicado: (2004)

Atherothrombosis in South Asians: Implications of Atherosclerotic and Inflammatory Markers
por: Dodani, Sunita
Publicado: (2010)

Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
por: ten Cate, Hugo, et al.
Publicado: (2016)

Flawed Reasoning Allows the Persistence of Mainstream Atherothrombosis Theory
por: Sloop, Gregory D, et al.
Publicado: (2018)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues
por: Gallego-Fabrega, Cristina, et al.
Publicado: (2020)

Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
por: Anfossi, Giovanni, et al.
Publicado: (2010)

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2017)

The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis
por: Moroni, Francesco, et al.
Publicado: (2019)

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches
por: Lopez-Pedrera, Chary, et al.
Publicado: (2019)

An extracardiac unruptured right sinus of valsalva aneurysm complicated with atherothrombosis
por: Zhang, Jun, et al.
Publicado: (2016)

Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques
por: Asada, Yujiro, et al.
Publicado: (2020)

Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
por: Otamas, Anastasia, et al.
Publicado: (2020)

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
por: Chu, Chih-Sheng, et al.
Publicado: (2020)

Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
por: Barbu, Elena, et al.
Publicado: (2022)

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
por: Violi, Francesco, et al.
Publicado: (2022)

Association Between Neighborhood Walkability and Predicted 10‐Year Cardiovascular Disease Risk: The CANHEART (Cardiovascular Health in Ambulatory Care Research Team) Cohort
por: Howell, Nicholas A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_afkprpamcu4464n3iore71ti6q